Home > Authors and editors

Sara Hanaei

Tehran University of Medical Sciences Iran

Dr. Sara Hanaei started medicine at TUMS in 2010 and received a Master of public health (MPH) degree in 2014. She graduated with MD-MPH in 2018. She also received a TUMS research diploma (TUMS-RD) in a two-year study period from 2013 to 2015. She was a research assistant at the Research Center for Immunodeficiencies (RCID) from 2018 to 2021 and further continued neurosurgery as a clinical specialty at TUMS in 2021. She has experience in teaching research skills to students. Medical research was one of her greatest interests since the beginning of her academic education, especially in neurosurgery and immunology; therefore, she started research in those fields. Over the past decade, she has contributed to different research projects, books, and other research activities including instructing research workshops in statistics, systematic reviews, and meta-analysis. She got involved in executive tasks and developed some executive skills through membership in the Universal Scientific Education and Research Network (USERN), where she experienced organizing scientific events, congresses, festivals, scoring, rankings, and so forth. She co-edited a two-volume book: - Human Brain and Spinal Cord Tumors: From Bench to Bedside. Volume 1 (Neuroimmunology and Neurogenetics) - Human Brain and Spinal Cord Tumors: From Bench to Bedside. Volume 2 (The Path to Bedside Management). In early 2024, she co-founded Borderless Research, Advancement, and Innovation in Neuroscience Network (BRAINet), which was intended to serve in a multidisciplinary and cross-disciplinary manner and embrace all aspects of neuroscience. On this account, different disciplines in neuroscience may come together in the BRAINet, including theoretical and molecular neuroscience, clinical neuroscience (neurology), surgical neuroscience (neurosurgery), and social neuroscience. In light of the borderless collaboration of seniors and juniors, it is provided to promote scientific activities and step forward to advancement and innovation in neuroscience.

1chapters authored

Latest work with IntechOpen by Sara Hanaei

Explore the world of meningiomas with Meningioma - The Essentials from Bench to Bedside, a definitive resource that bridges the gap between the latest research and clinical practice. This comprehensive volume dives into the molecular and genetic underpinnings of meningiomas, offering a deep understanding of their pathology and diagnosis. The book provides invaluable insights into patient-centered care, highlighting the impact of meningiomas on quality of life and advocating for holistic treatment approaches. With a focus on advanced therapeutic options, including state-of-the-art radiosurgery, it presents the latest techniques and strategies to effectively manage and treat these complex tumors. Whether you are a seasoned professional or a newcomer to the field, this book equips you with the knowledge and tools necessary to improve patient outcomes and advance your expertise. Meningioma - The Essentials from Bench to Bedside is a review of the current understanding of meningiomas offering a wealth of information in a single, accessible volume.

Meningioma

Meningioma

Edited by Sara Hanaei

Chapters authored

Introductory Chapter: Meningioma – The Essentials from Bench to Bedside

By Seyed Farzad Maroufi and Sara Hanaei

Meningiomas arising from the meningeal layers are the most prevalent primary central nervous system (CNS) tumors.[1] These lesions comprise more than 35% of CNS tumors and present a complex and enigmatic challenge in the field of neurosurgery. These tumors are characterized by their slow growth, variable clinical manifestations, and intricate histopathological features. First identified by Rudolf Virchow in the 19th century, meningiomas have since been the subject of extensive research and clinical scrutiny, leading to a deeper understanding of their biology, classification, and therapeutic approaches.[2] The incidence of meningiomas is reported to be 1.8 to 13 per 100,000 persons per year, with more than 170,000 affected individuals in the United States.[4, 5] Accurate diagnosis of meningiomas relies on a combination of clinical evaluation, neuroimaging studies, and histopathological examination. Magnetic Resonance Imaging (MRI) is the modality of choice for the assessment of meningiomas. The therapeutic approach to meningiomas is guided by several factors, including tumor size, location, histological grade, patient age, and comorbidities, as well as the presence of symptoms and neurological deficits. Treatment modalities for meningiomas include observation, surgical resection, radiation therapy, and, rarely, systemic therapy.

Part of the book: Meningioma

Related collaborators

Frank Y. Shan

Texas A&M Health Science Center , United States of America

Jason H. Huang

Baylor Scott & White Health , United States of America

Karming Fung

University of Oklahoma Health Sciences Center , United States of America

Yi-lu Zhang

Dong-xia Feng

Farnam Mohebi

Mohsen Merati

Jennifer Murillo

Fateme Montazeri

Department of Ophthalmology & Vision Sciences, University of California, Davis, Sacramento, California, US

Hannaneh Kabir

Department of Bioengineering, University of California, Berkeley, California, US